Search NLS News

In March 2022, the Wallenberg foundations announced financial support for the employment of Ukrainian scientists at Swedish universities. Following the launch of an open call targeting the SciLifeLab research environment, seven Ukrainian scientists are now recruited at four different universities (UU, UmU, KI, SLU). “At present, when the lives and plans of many Ukrainians are […]

BerGenBio has announced the appointment of Cristina Oliva as Chief Medical Officer (CMO). Cristina Oliva joins the senior leadership team heading up clinical development of BerGenBio’s selective AXL inhibitor programs. “I’m delighted to welcome Cristina as our new Chief Medical Officer. Cristina’s leadership experience within oncology drug development across big pharma, biotech and CRO environments […]

BC Platforms, Euformatics and Oncompass Medicine have formed a partnership to bid for the development of standardized oncology workflows for a buyer consortium of seven leading hospitals based in Central Europe. The buyer consortium, represented by the Medical University Graz, evaluated all proposals, and awarded a contract to the consortium of BC Platforms, Euformatics and […]

XNK Therapeutics recently secured a private placement of 132 million SEK, enabling progress of the company’s development of new NK cell-based therapies. Since its foundation ten years ago, Swedish XNK Therapeutics has been developing novel autologous natural killer (NK) cell-based therapies targeting cancer. The company’s technology platform includes assets related to the investigational drug product […]

EpiEndo Pharmaceuticals has completed its Phase I First Time in Human (FTIH) study with EP395 in healthy subjects. EP395 is the first of EpiEndo’s orally available, non-antibiotic macrolides or ‘Barriolides’ to enter clinical development and will be targeting chronic obstructive pulmonary disease (COPD). Read more: A Nordic star on a global mission The study was […]

The Rhode Island Department of Health has granted Immunovia, Inc., the US subsidiary of Immunovia, Clinical Laboratory licensure. The licensure allows physicians in Rhode Island to order the IMMray PanCan-d test for their patients. “Receiving licensure in Rhode Island now allows us to offer IMMray PanCan-d in 46 states. We expect additional state licensures to […]

Viktoriia Tsuber worked as a professor and scientist in Poltava State Medical University, in Poltava, Ukraine. She left the country when the war started and she is now continuing her research at Karolinska Institutet in Solna. During her research in Ukraine, Viktoriia Tsuber used methods within the field of bioinformatics to analyze big data sets […]

As sustainability regulations tighten, the life science industry faces increasing expectations from consumers and investors. Keeping track of regulations, finding enough staff resources, and showcasing the work are some of the challenges companies face. In late 2021, the life-science industry association SwedenBIO carried out a sustainability poll among its member companies. The results, based on […]

Professor of Medical Biochemistry Klaus Elenius from the University of Turku has been selected for the position of the Scientific Director of BioCity Turku. The vacancy lasts five years and started on 1 January 2022. A key position BioCity Turku is a joint organization of the University of Turku and Åbo Akademi University, supporting and […]

Industrifonden strengthens its life science team by recruiting Fredrik Lehmann as Venture Partner. Fredrik Lehmann has more than 20 years of experience from the life science industry, as CEO and Head of Research and CMC in several companies. He has founded six companies, including OnTarget Chemistry acquired by Recipharm in 2015. “We are excited to […]